Digital Infosession: Keeping an eye on belantamab mafodotin – mitigating ocular toxicities
Watch the recording
The session featured:
Download the slide set
Explore more on the Myeloma UK HCP Hub
This session is just one of many resources available on the Myeloma UK HCP Hub. Sign up to access:
- Previous webinars
- Free tools and resources to support your practice
- Hot topics and discussions from clinicians
Use Cases
Type
Sources
Content Collection
You might also like
Digital Infosession: Frailty and myeloma: the unmet clinical need
In the fifth co-partnered digital infosession from Myeloma UK and UKMS, held on 26 March 2025 and chaired by Professor Guy Pratt, leading clinicians explored the pressing issue of frailty in myeloma patients. The session focused on effective strategies for assessing frailty risk and integrating these practices into everyday clinical care.
Digital Infosession: Renal disease in myeloma and related conditions
The fourth co-partnered digital infosession from Myeloma UK and UKMS, held on 16 October 2024 and hosted by Professor Gordon Cook, covers cutting-edge strategies for managing renal complications in myeloma, including myeloma cast nephropathy, paraprotein-related kidney disease, and comprehensive treatment and supportive care approaches.
Digital Infosession: Guidance for managing bone disease and optimal imaging for patients with myeloma
Joining forces once again, Myeloma UK and the UK Myeloma Society (UKMS) proudly present their third co-partnered digital infosession. Chaired by Professor Guy Pratt, this webinar, held on 16 April 2024, brought together top experts for an engaging discussion on effective strategies for managing bone disease in myeloma patients.
Digital Infosession: Effective management of multidisciplinary MGUS and myeloma clinics
Myeloma UK and the UK Myeloma Society (UKMS) are excited to present their second co-partnered digital infosession, chaired by Prof. Guy Pratt. This webinar, recorded on 18 October 2023, features leading experts discussing best practices for managing multidisciplinary clinics, offering valuable guidance for healthcare professionals involved in MGUS and myeloma care.
Digital Infosession: BCMA and GPRC5D antibodies in practice: Implementation and management for healthcare professionals
Myeloma UK and the UK Myeloma Society (UKMS) proudly present their first co-partnered digital infosession. This recording of the live event, held on 19 April 2023, features expert speakers from medicine, nursing, and pharmacy, sharing insights on the innovation journey of these treatments such as bispecific antibodies and offering practical guidance on their implementation and management in clinical practice.